Alerislife Inc Revenue Growth Rates (ALR), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Alerislife Inc   (NASDAQ: ALR)
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare
 

ALR's Revenue Growth by Quarter and Year

Alerislife Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ALR Revenue (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
4th Quarter December -
3rd Quarter September 182.66
2nd Quarter June 171.12
1st Quarter March 173.14
FY 526.92

ALRs Annual Revenue
Alerislife Inc 's Revenue in the fiscal year 2021 $ 934.59 millions
Alerislife Inc 's Revenue in the fiscal year 2016 $ 2,376.34 millions
Alerislife Inc 's Revenue in the fiscal year 2015 $ 2,463.32 millions
Alerislife Inc 's Revenue in the fiscal year 2014 $ 2,588.70 millions
Alerislife Inc 's Revenue in the fiscal year 2013 $ 3,029.44 millions




ALR Revenue third quarter 2022 Y/Y Growth Comment
Alerislife Inc reported decline in Revenue in the third quarter 2022 by -19.12% to $ 182.66 millions, from the same quarter in 2021.
The contraction in the third quarter 2022 Alerislife Inc 's Revenue compares unfavorably to the Company's average Revenue decrease of -2.99%.

Looking into third quarter 2022 results within Healthcare Facilities industry 20 other companies have achieved higher Revenue growth. While Alerislife Inc ' s Revenue fall of -19.12% ranks overall at the positon no. 900 in the third quarter 2022.


ALR Revenue ( Y/Y Growth %) 2022
 2021 2020 2019
4th Quarter December - -36.34 % -51.65 % 0.22 %
3rd Quarter September -19.12 % -23.53 % -51.16 % -2.02 %
2nd Quarter June -33.83 % -9.76 % -50.79 % -3.27 %
1st Quarter March -35.66 % -51.75 % -8.74 % -2.87 %
FY   - -34.37 % -40.33 % -

Financial Statements
Alerislife Inc 's third quarter 2022 Revenue $ 182.66 millions ALR's Income Statement
Alerislife Inc 's third quarter 2021 Revenue $ 225.83 millions Quarterly ALR's Income Statement


ALR Revenue (Quarter on Quarter Growth %)

 2022
 2021 2020 2019
4th Quarter December - -19.83 % -3.7 % -2.72 %
3rd Quarter September 6.74 % -12.68 % 3.05 % 3.83 %
2nd Quarter June -1.17 % -3.89 % -48.61 % -4.7 %
1st Quarter March -4.36 % -5.38 % -5.19 % 4.11 %
FY (Year on Year)   - -34.37 % -40.33 % -


Back to ALR Growth rate Comparisons >> Back to ALR Growth rate Comparisons >>


Revenue third quarter 2022 Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry #21
Healthcare Sector #104
Overall #900

Revenue Y/Y Growth Statistics
High Average Low
10.2 % -2.99 % -10.43 %
  (Jun 30 2022)
Revenue third quarter 2022 Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry #21
Healthcare Sector #104
Overall #900
Revenue Y/Y Growth Statistics
High Average Low
10.2 % -2.99 % -10.43 %
  (Jun 30 2022)

Revenue by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Alerislife Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
25.41 % -0.16 % -25.3 %
(Mar 31 2015)  


ALR's III. Quarter Q/Q Revenue Comment
Alerislife Inc achieved in the III. Quarter 2022 above company average sequential Revenue increase of 6.74%, to $ 182.66 millions, from $171.12 millions in the second quarter.
ALR is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.

Within Healthcare Facilities industry 8 other companies have achieved higher Revenue quarter on quarter growth. While Alerislife Inc 's Revenue growth quarter on quarter, overall rank is 1539.


Revenue Q/Q Growth Company Ranking
Within: No.
Healthcare Facilities Industry #9
Healthcare Sector #272
Overall #1539
Revenue Q/Q Growth Company Ranking
Within: No.
Healthcare Facilities Industry #9
Healthcare Sector #272
Overall #1539
Revenue Q/Q Growth Statistics
High Average Low
25.41 % -0.16 % -25.3 %
(Mar 31 2015)  


ALR's III. Quarter Q/Q Revenue Comment
Alerislife Inc achieved in the III. Quarter 2022 above company average sequential Revenue increase of 6.74%, to $ 182.66 millions, from $171.12 millions in the second quarter.
ALR is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.

Within Healthcare Facilities industry 8 other companies have achieved higher Revenue quarter on quarter growth. While Alerislife Inc 's Revenue growth quarter on quarter, overall rank is 1539.


Alerislife Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Sep 30 2022)		 12 Months Ending
(Jun 30 2022)		 12 Months Ending
(Mar 31 2022)		 12 Months Ending
(Dec 31 2021)		 12 Months Ending
(Jun 30 2017)
Cumulative Revenue 12 Months Ending $ 707.97 $ 751.14 $ 838.64 $ 934.59 $ 2,332.93
Y / Y Revenue Growth (TTM) -31.79 % -32.17 % -26.14 % -34.37 % -3.49 %
Year on Year Revenue Growth Overall Ranking # 2928 # 1873 # 1375 # 1508 # 2627
Seqeuential Revenue Change (TTM) -5.75 % -10.43 % -10.27 % -9.96 % -2.24 %
Seq. Revenue Growth (TTM) Overall Ranking # 2882 # 1948 # 1417 # 1577 # 2610


Cumulative Revenue growth Comment
Alerislife Inc showed decline, but improvement compare to trailing twelve month Revenue decrease in Jun 30 2022. If the fiscal year would end in Sep 30 2022, Alerislife Inc 's annual Revenue decline would be -31.79% year on year to $708 millions.

In the Healthcare sector 394 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 1873 to 2928.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry # 32
Healthcare Sector # 395
Overall # 2928

Revenue TTM Y/Y Growth Statistics
High Average Low
7.47 %
 -10.46 %
-34.37 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 32
Sector # 390
S&P 500 # 2882
Cumulative Revenue growth Comment
Alerislife Inc showed decline, but improvement compare to trailing twelve month Revenue decrease in Jun 30 2022. If the fiscal year would end in Sep 30 2022, Alerislife Inc 's annual Revenue drop would be -31.79% year on year to $708 millions.

In the Healthcare sector 394 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 1873 to 2928.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry # 32
Healthcare Sector # 395
Overall # 2928

Revenue TTM Y/Y Growth Statistics
High Average Low
7.47 %
-10.46 %
-34.37 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 32
Sector # 390
S&P 500 # 2882




Other Revenue Growth
Healthcare Facilities Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
ALR's Revenue Growth Ratio versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue drop for the quarter ending Sep 30 2022 within Healthcare SectorY/Y Change %Revenue for the quarter ending Sep 30 2022
Nrc Health-0.20%$ -0.201 millions
Livanova Plc-0.24%$ -0.241 millions
Healthcare Services Group Inc -0.27%$ -0.265 millions
Catalent Inc -0.29%$ -0.293 millions
Asensus Surgical Inc -0.31%$ -0.311 millions
Liquidia Corporation-0.43%$ -0.429 millions
Integra Lifesciences Holdings Corp-0.43%$ -0.432 millions
Pediatrix Medical Group Inc -0.62%$ -0.615 millions
China Pharma Holdings Inc-0.64%$ -0.642 millions
Acadia Pharmaceuticals Inc -0.68%$ -0.682 millions
Bausch and Lomb Corp-0.74%$ -0.738 millions
Amgen Inc -0.81%$ -0.805 millions
Syneos Health Inc -0.89%$ -0.891 millions
Hologic Inc-0.93%$ -0.925 millions
Innovage Holding Corp -1.07%$ -1.070 millions
Regen Biopharma Inc -1.09%$ -1.088 millions
Procyon Corporation-1.20%$ -1.200 millions
Precipio inc -1.38%$ -1.380 millions
Ati Physical Therapy Inc -1.40%$ -1.397 millions
Ocular Therapeutix Inc -1.55%$ -1.547 millions
Alpine Immune Sciences Inc -1.75%$ -1.750 millions
Surgalign Holdings Inc -1.79%$ -1.786 millions
Tenet Healthcare Corp-1.90%$ -1.900 millions
Teleflex Incorporated-1.92%$ -1.923 millions
Novocure Limited-1.95%$ -1.952 millions
Fresenius Medical Care Ag-1.99%$ -1.990 millions
Hca Healthcare Inc -2.00%$ -1.997 millions
Dynatronics Corporation-2.01%$ -2.014 millions
Royalty Pharma Plc-2.10%$ -2.101 millions
National Healthcare Corp-2.13%$ -2.130 millions


About Alerislife Inc Revenue Growth Rates (ALR), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: the company’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.